1. Sulfinosine-Induced Cell Growth Inhibition and Apoptosis in Human Lung Carcinomas In Vitro

   • Javorina Milošević
   • Selma Kanazir
   • Sabera Ruždijić

   OriginalPaper Pages: 229 - 240

2. Antiangiogenic and Antitumor Effects of a Protein Kinase Cβ Inhibitor in Human Breast Cancer and Ovarian Cancer Xenografts

   • Beverly A. Teicher
   • Krishna Menon
   • Margaret M. Faul

   OriginalPaper Pages: 241 - 251

3. A Novel High-Through-Put Assay for Screening of Pro-Apoptotic Drugs

   • Maria Hägg
   • Kenneth Bivén
   • Stig Linder

   OriginalPaper Pages: 253 - 259

4. Preclinical Antitumor Activity and Pharmacokinetics of Methyl-2-Benzimidazolecarbamate (FB642)

   • Desirée Hao
   • Jinee D. Rizzo
   • Steven D. Weitman

   OriginalPaper Pages: 261 - 270

5. Enhanced Antitumor Activity of Irofulven in Combination with Antimitotic Agents

   • Michael J. Kelner
   • Trevor C. McMorris
   • Pharnuk Suthipinijtham

   OriginalPaper Pages: 271 - 279

6. 5,6-Dimethylxanthenone-4-Acetic Acid (DMXAA): a New Biological Response Modifier for Cancer Therapy

   • Shufeng Zhou
   • Philip Kestell
   • James W. Paxton

   OriginalPaper Pages: 281 - 295

7. A Phase I and Pharmacologic Study of Pyrazoloacridine (NSC 366140) and Carboplatin in Patients with Advanced Cancer

   • Alex A. Adjei
   • Joel M. Reid
   • Scott H. Kaufmann

   OriginalPaper Pages: 297 - 304

8. A Phase I Trial of Weekly Gemcitabine and Subcutaneous Interferon Alpha in Patients with Refractory Renal Cell Carcinoma

   • F. Perez-Zincer
   • T. Olencki
   • R.M. Bukowski

   OriginalPaper Pages: 305 - 310

9. A Report on Serious Pulmonary Toxicity Associated with Gemcitabine-Based Therapy

   • Debasish F. Roychowdhury
   • Catherine A. Cassidy
   • Michael Arning

   OriginalPaper Pages: 311 - 315

10. Phase I/II Study of Gemcitabine and Vinorelbine Plus Cisplatin in Non-Small Cell Lung Cancer

    • Emilio Esteban
    • Joaquín Fra
    • Angel J. Lacave

    OriginalPaper Pages: 317 - 326

11. Phase II Trial of Arsenic Trioxide in Patients with Metastatic Renal Cell Carcinoma

    • Jacqueline Vuky
    • Richard Yu
    • Robert J. Motzer

    OriginalPaper Pages: 327 - 330

12. A Phase II Study of Caelyx^TM (Liposomal Doxorubicin) in Metastatic Carcinoma of the Prostate: Tolerability and Efficacy Modification by Liposomal Encapsulation

    • Rhona McMenemin
    • Graham Macdonald
    • Donald Bissett

    OriginalPaper Pages: 331 - 337

13. Phase II Trial of Pyrazoloacridine in Advanced Non-Small Cell Carcinoma of the Lung: A Kansas Cancer Institute and Thompson Cancer Survival Center Study

    • Michael Bastasch
    • Timothy J. Panella
    • Stephen Williamson

    OriginalPaper Pages: 339 - 342

14. A Phase I Study of SPI-077 (Stealth® Liposomal Cisplatin) Concurrent with Radiation Therapy for Locally Advanced Head and Neck Cancer

    • David I. Rosenthal
    • Sue S. Yom
    • Diane Hershock

    OriginalPaper Pages: 343 - 349

15. Outpatient Therapy with Gemcitabine and Docetaxel for Gallbladder, Biliary, and Cholangio-Carcinomas

    • Roger Kuhn
    • Arndt Hribaschek
    • Karsten Ridwelski

    OriginalPaper Pages: 351 - 356

16. A Phase II Study of Irofulven (MGI 114) in Patients with Stage IV Melanoma

    • A. Scott Pierson
    • Peter Gibbs
    • Rene Gonzalez

    OriginalPaper Pages: 357 - 362

17. Instructions for Authors

    Instructions for Authors Pages: 363 - 367